Ropes & Gray is a proud sponsor of the Align Summit, MassBio’s annual early-stage and funder partnering conference, on October 7 at the Boston Marriott Copley Place. The conference seeks to connect funders and biotech startups to help develop next-generation therapies.
This year, 56 emerging life sciences companies will present at the conference under the following tracks:
- AI/ML-Driven Drug Design, Discovery, Development: This track will highlight companies using artificial intelligence and machine learning (AI/ML) to transform drug discovery and development.
- Next-Generation Multispecific Therapeutics: This track will feature companies focused on cutting-edge advancements in multi-specific therapies, emphasizing their ability to address complex biological pathways and improve targeted delivery mechanisms.
- The Future of Precision Therapies: This track will feature companies focused using precision therapies that customize treatments based on individual genetic, molecular, or biomarker profiles.
- Early-Stage Biotech and Techbio Presentations: This track will feature the 2025 graduates of the Drive accelerator, fueled by MassBio and SCbio.
The conference also will include thought leadership sessions and partnering meetings. More information can be found on MassBio’s website.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.